☆ 4.7 Meeting Abstract

Prevention of Relapse in Schizophrenia: A Phase II Study Evaluating Efficacy, Safety, and Tolerability of Oral BI 409306

BIOLOGICAL PSYCHIATRY (2018)

Get Full Text
Add to Collection

Journal

BIOLOGICAL PSYCHIATRY
Volume 83, Issue 9, Pages S421-S421

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2018.02.1082

Keywords

Clinical Trials; Efficacy; Phosphodiesterase 9 Inhibitor; Relapse; Schizophrenia

Categories

Neurosciences Psychiatry

Funding

  1. Boehringer Ingelheim [1289.49]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.